Articles Tagged With: vaccine
-
Texas Judge Tosses Suit Over COVID-19 Vaccine Mandate
Plaintiffs expected to challenge ruling in ongoing saga over Houston facility’s policy. -
The Cost-Effectiveness of HPV Vaccination for Adults Age 30 to 45 Years
Researchers found extending the upper limit of HPV vaccination to age 30 to 45 years is not cost-effective. -
FDA, CDC Back COVID-19 Vaccine for Adolescents
The Pfizer/BioNTech solution will be available for Americans age 12 to 15 years. -
U.S. Supports Waiving Intellectual Property Protections for COVID-19 Vaccines
The aim is to accelerate the spread of shots around the globe.
-
CDC OKs Johnson & Johnson Vaccine with Warning to Women Younger Than 50 Years
Federal health officials have lifted the pause on Johnson & Johnson’s one-shot Janssen COVID-19 vaccine, but women younger than age 50 years should know the risks of the rare but real side effect.
-
2021 Update on Adult Vaccinations with a Focus on SARS-CoV-2/COVID-19
Vaccination in adults remains one of the most important means of preventing disease in vulnerable populations. Certain vaccines, such as influenza, tetanus/diphtheria/pertussis, and the new COVID-19 vaccine are recommended for all adults, while others are recommended in subsets of adults depending on age, comorbidities, and certain risk factors.
-
White Adults, Women Overrepresented in U.S. Vaccine Trials
Investigators uncover reporting gaps, lack of proper representation for older adults, minority groups.
-
Herpes Zoster Vaccine: Effective but Underused
The adjuvanted recombinant herpes zoster vaccine is highly effective in practice, but it is vastly underused.
-
United Kingdom Begins First COVID-19 Human Challenge Study
Lawmakers, academics, and the research community have hotly debated the ethics of a human challenge study since the first months of the COVID-19 pandemic. Now that the United Kingdom has started dosing patients in its human challenge study, some bioethicists say this trial can show vaccine efficacy in ways the larger vaccine trials cannot.
-
Study of COVID-19 Vaccine in Pregnant People ‘Too Late’
On Feb. 18, Pfizer and BioNTech announced they would dose about 4,000 healthy pregnant women with the COVID-19 vaccine to evaluate its safety, tolerability, and immunogenicity. Although pregnant people were excluded initially from the COVD-19 trials, research has shown they are at higher risk for more severe disease.